iCONNECT with Baxter Canada

From Efficiency Gains to Enhanced Patient Safety: Addressing Staffing Shortages with Frozen Ready-to-Use Premixes

29 min · 10. nov. 2023
episode From Efficiency Gains to Enhanced Patient Safety: Addressing Staffing Shortages with Frozen Ready-to-Use Premixes cover

Description

In this episode, Pharmacy Manager Dr. Neubauer will share her experience of being the first to implement frozen IV premixes within the Saskatchewan Health Authority. She will explain how her community hospital site first got involved, explain how they navigated through change management despite staffing shortages, and provide considerations for other organizations looking to introduce these products.

Comments

0

Be the first to comment

Sign up now and become a member of the iCONNECT with Baxter Canada community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

31 episodes

episode Improving the Safety of High Risk Insulin Infusions with Dr. Kevin Hansen artwork

Improving the Safety of High Risk Insulin Infusions with Dr. Kevin Hansen

IV Insulin has been defined as a top-rated high-alert medication by the Institute for Safe Medication Practices, and yet options to improve the safety of these infusions have been limited until recently.  Dr. Kevin Hansen will discuss his experience using Myxredlin, a ready-to-administer insulin infusion product that has changed how many organizations manage these high-risk infusions in the US.  He will also introduce some of the concepts for consideration when organizations are exploring the introduction of ready-to-administer products including patient safety, pharmaco-economics, drug stability, human resource management, and workflows. Link to discussed publication:  https://www.pppmag.com/article/2655 [https://www.pppmag.com/article/2655]

5. juni 202323 min